CELTIC PHARMA INTERNATIONAL Trademark

Trademark Overview

On Friday, February 6, 2009, a trademark application was filed for CELTIC PHARMA INTERNATIONAL with the United States Patent and Trademark Office. The USPTO has given the CELTIC PHARMA INTERNATIONAL trademark a serial number of 77665168. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 9, 2012. This trademark is owned by Celtic Therapeutics Management LLLP. The CELTIC PHARMA INTERNATIONAL trademark is filed in the Insurance & Financial Services and Computer & Software Services & Scientific Services categories with the following description:

management of private equity funds in the biomedical field; private equity fund investment services in the biomedical field

Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development
celtic pharma international

General Information

Serial Number77665168
Word MarkCELTIC PHARMA INTERNATIONAL
Filing DateFriday, February 6, 2009
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 9, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 15, 2009

Trademark Statements

Disclaimer with Predetermined Text"PHARMA INTERNATIONAL"
Goods and Servicesmanagement of private equity funds in the biomedical field; private equity fund investment services in the biomedical field
Goods and ServicesConducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, February 10, 2009
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 10, 2009
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCeltic Therapeutics Management LLLP
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSt. Thomas 00804
VI
Party NameCeltic Therapeutics Management LLLP
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSt. Thomas 00804
VI

Trademark Events

Event DateEvent Description
Monday, April 9, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 9, 2012ABANDONMENT - NO USE STATEMENT FILED
Saturday, September 10, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 9, 2011EXTENSION 3 GRANTED
Wednesday, September 7, 2011EXTENSION 3 FILED
Wednesday, September 7, 2011TEAS EXTENSION RECEIVED
Friday, February 11, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 9, 2011EXTENSION 2 GRANTED
Wednesday, February 9, 2011EXTENSION 2 FILED
Wednesday, February 9, 2011TEAS EXTENSION RECEIVED
Saturday, October 2, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 1, 2010EXTENSION 1 GRANTED
Wednesday, September 8, 2010EXTENSION 1 FILED
Friday, October 1, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 8, 2010TEAS EXTENSION RECEIVED
Wednesday, September 8, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 8, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 9, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 15, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2009PUBLISHED FOR OPPOSITION
Thursday, November 12, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, November 12, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 2, 2009EXAMINER'S AMENDMENT ENTERED
Friday, October 30, 2009ASSIGNED TO LIE
Friday, October 30, 2009NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 30, 2009EXAMINERS AMENDMENT E-MAILED
Friday, October 30, 2009EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 14, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 14, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 14, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 5, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 5, 2009NON-FINAL ACTION E-MAILED
Tuesday, May 5, 2009NON-FINAL ACTION WRITTEN
Monday, April 27, 2009ASSIGNED TO EXAMINER
Tuesday, February 10, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, February 10, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

international pharma celtic pharmaceutical development field services research biomedical equity private testing laboratory